A phase II study of FOLFIRI-3 (double infusion of irinotecan combined with LV5FU) after FOLFOX in advanced colorectal cancer patients

por Mabro, M, Artru, P, André, T, Flesch, M, Maindrault-Goebel, F, Landi, B, Lledo, G, Plantade, A, Louvet, C, de Gramont, A
Publicado 2006

Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly

por Aparicio, T, Desramé, J, Lecomte, T, Mitry, E, Belloc, J, Etienney, I, Montembault, S, Vayre, L, Locher, C, Ezenfis, J, Artru, P, Mabro, M, Dominguez, S
Publicado 2003

Phase II study of UFT with leucovorin and irinotecan (TEGAFIRI): first-line therapy for metastatic colorectal cancer

por Delord, J-P, Bennouna, J, Artru, P, Perrier, H, Husseini, F, Desseigne, F, François, E, Faroux, R, Smith, D, Piedbois, P, Naman, H, Douillard, J Y, Bugat, R
Publicado 2007